about
Polymorphism of the gene encoding a human minimal potassium ion channel (minK)Next-generation sequencing of nine atrial fibrillation candidate genes identified novel de novo mutations in patients with extreme trait of atrial fibrillation.Myocardial Regional Interstitial Fibrosis is Associated With Left Intra-Ventricular Dyssynchrony in Patients With Heart Failure: A Cardiovascular Magnetic Resonance Study.Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.Characteristics of Chinese patients with symptomatic Brugada syndrome in Taiwan.Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutationsBrugada-type electrocardiogram in the Taiwanese population--is it a risk factor for sudden death?Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndromeUnique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan.Functional genomic study on atrial fibrillation using cDNA microarray and two-dimensional protein electrophoresis techniques and identification of the myosin regulatory light chain isoform reprogramming in atrial fibrillation.Renin-angiotensin system gene polymorphisms and atrial fibrillation.Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes.Perfusion index derived from a pulse oximeter can detect changes in peripheral microcirculation during uretero-renal-scopy stone manipulation (URS-SM).A new method to derive fetal heart rate from maternal abdominal electrocardiogram: monitoring fetal heart rate during cesarean section.Molecular genetic studies in atrial fibrillation.Genome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillationRepolarization Alternans and Ventricular Arrhythmia in a Repaired Tetralogy of Fallot Animal Model.Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.The clinical implications of blood adiponectin in cardiometabolic disorders.Utilizing multiple in silico analyses to identify putative causal SCN5A variants in Brugada syndrome.Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway.C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study.TNF-α down-regulates sarcoplasmic reticulum Ca²⁺ ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-κB to promoter response element.Renin-angiotensin system gene polymorphisms predict the risk of stroke in patients with atrial fibrillation: a 10-year prospective follow-up study.Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.Mechanical stretch of atrial myocyte monolayer decreases sarcoplasmic reticulum calcium adenosine triphosphatase expression and increases susceptibility to repolarization alternans.A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation.Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblasts.The g.-762T>C polymorphism of the NPC1L1 gene is common in Chinese and contributes to a higher promoter activity and higher serum cholesterol levels.Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation.Prevalence and prognosis of Brugada electrocardiogram patterns in an elderly Han Chinese population: a nation-wide community-based study (HALST cohort).Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis.Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.Significant association of rs13376333 in KCNN3 on chromosome 1q21 with atrial fibrillation in a Taiwanese population.Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation.Global distribution of atrial ectopic foci triggering recurrence of atrial tachyarrhythmia after electrical cardioversion of long-standing atrial fibrillation: a bi-atrial basket mapping study.Electrophysiological mapping and histological examinations of the swine atrium with sustained (> or =24 h) atrial fibrillation: a suitable animal model for studying human atrial fibrillation.
P50
Q28305825-B24DD856-C937-468C-9549-B15B17C65B31Q30368601-F743DAFE-6C19-45FB-AAD1-BE5AC4631BE7Q30391425-C968A314-5535-4612-9AD6-C2E2BA941650Q30886019-5F54FB78-330F-4E8B-97C3-236A5CDD3DA2Q33149124-2E10B2FE-AA95-43C4-A5DD-67C3116AD529Q33150718-3D8C2912-D920-4177-AD9F-639F63367169Q33157184-D3B0FB5B-D9DA-47E2-8CDF-18B2FBEBDE5DQ33160000-62A6BDA5-5826-43C5-B149-8AF78E0893EFQ33164900-FF7F6A17-5816-4C56-A7EF-E6AB1957AB2BQ33165990-74413834-6A9A-412F-965E-FC81A50D6EF3Q33199739-A02B6ACB-3D98-4E72-91E1-AE4633C2AC9DQ34306157-075ABD2A-D2BA-4B3E-B9D2-29623662E162Q34564767-6D46CC9D-E88B-4851-8AA3-D5CB379324CFQ34776711-BCC2544B-5851-4CDF-B00C-B02D0695829EQ35101685-2B90EAB4-55A2-40F4-B6A0-F4DDDA910F4FQ35590227-C18C2879-5202-440A-B10F-DEED606A987AQ36542196-87ED33D3-42A4-4FA5-9E3D-4ED8475FC5BEQ36836435-23CF541E-7D12-4887-985B-0C5B3ADFDB5CQ37359567-A7BC4018-9E48-4EC9-BFD7-EB60BCC2CBD8Q37482881-067B3289-5CEF-4D0B-895B-C59B9D907853Q37517198-9464FD30-42E4-4D13-8F05-7E03C46B961EQ37729882-88BA5C00-B09F-4B03-86E8-C3B737CB30EEQ38789345-923A0CE6-2BBE-446E-A227-11281690E0A3Q38906308-88420A4A-9F2A-4DF6-AF46-FAA60E8E8EFAQ39209784-8FB5ECCF-B905-4D27-839E-8B20835B5F56Q39311954-50FE00BD-D9F7-442C-9C1C-CB0FC37BCDC0Q39448483-970D0DEF-2AC7-49B0-A108-21863228154FQ39653047-153A1D20-BCA2-41D9-8E45-DBA3F25E29DBQ39685036-F57BCBBC-B377-43CD-9495-223274D165F4Q39876267-8B81E34D-0CB3-4205-8D59-3CC01511792DQ40008861-F87CC56C-3EAA-4144-8742-C71997EFC8B4Q40027033-64C868BC-935F-473A-AB82-48AF4794E3C0Q40588847-202FCB06-A99B-4DBE-905D-972EBABDADC0Q40591063-432DE873-956A-4B7E-9E82-354737B73DA1Q42467533-A049FC7F-C5D7-4147-9DBA-A991B5EBAA73Q43003607-01417B37-1FAA-4D1D-939D-AB217BA9FD27Q43459422-D66F3A16-E79E-40F5-8744-3BDBA7399E12Q43514140-07CD5304-2068-4EE0-9416-572DA2BEA7D8Q43788612-E9DDAE73-8761-493C-9753-E5C994559CECQ44414814-5C63FC92-6B7A-42BF-918E-82D2BF9007B1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ling-Ping Lai
@ast
Ling-Ping Lai
@de
Ling-Ping Lai
@en
Ling-Ping Lai
@es
Ling-Ping Lai
@fr
Ling-Ping Lai
@nds
Ling-Ping Lai
@nl
type
label
Ling-Ping Lai
@ast
Ling-Ping Lai
@de
Ling-Ping Lai
@en
Ling-Ping Lai
@es
Ling-Ping Lai
@fr
Ling-Ping Lai
@nds
Ling-Ping Lai
@nl
prefLabel
Ling-Ping Lai
@ast
Ling-Ping Lai
@de
Ling-Ping Lai
@en
Ling-Ping Lai
@es
Ling-Ping Lai
@fr
Ling-Ping Lai
@nds
Ling-Ping Lai
@nl
P106
P1153
7202616256
P31
P496
0000-0002-9651-7420